Omega Healthcare Investors (NYSE:OHI) Hits New 12-Month High – Still a Buy?

Omega Healthcare Investors, Inc. (NYSE:OHI)’s share price hit a new 52-week high on Wednesday . The stock traded as high as $50.10 and last traded at $49.5970, with a volume of 1487329 shares changing hands. The stock had previously closed at $49.02.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $47.00 to $48.00 and gave the stock a “sector perform” rating in a research note on Monday, May 4th. Scotiabank reduced their price objective on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Citigroup reiterated a “market perform” rating on shares of Omega Healthcare Investors in a research report on Monday, June 15th. Raymond James Financial initiated coverage on shares of Omega Healthcare Investors in a research note on Tuesday, June 16th. They set an “outperform” rating and a $50.00 target price on the stock. Finally, Truist Financial dropped their price target on shares of Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating on the stock in a research report on Tuesday, June 9th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $48.50.

Omega Healthcare Investors Trading Up 1.2%

The company has a quick ratio of 5.32, a current ratio of 5.32 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $14.77 billion, a P/E ratio of 23.96, a PEG ratio of 2.09 and a beta of 0.58. The firm’s 50-day simple moving average is $46.82 and its 200 day simple moving average is $45.96.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The firm had revenue of $322.95 million for the quarter, compared to analysts’ expectations of $264.07 million. During the same period in the prior year, the company posted $0.75 earnings per share. Omega Healthcare Investors’s quarterly revenue was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 3.1 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, May 4th were issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 5.4%. The ex-dividend date was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 129.47%.

Institutional Trading of Omega Healthcare Investors

A number of institutional investors and hedge funds have recently modified their holdings of OHI. State Street Corp grew its stake in Omega Healthcare Investors by 4.8% in the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after buying an additional 671,473 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Omega Healthcare Investors by 9.4% during the fourth quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock valued at $377,648,000 after acquiring an additional 734,774 shares during the period. Invesco Ltd. boosted its holdings in Omega Healthcare Investors by 8.6% during the fourth quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock valued at $238,059,000 after acquiring an additional 424,024 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Omega Healthcare Investors by 4.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock valued at $197,927,000 after purchasing an additional 174,062 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of Omega Healthcare Investors by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 4,457,975 shares of the real estate investment trust’s stock valued at $197,667,000 after purchasing an additional 696,759 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.